ATE430799T1 - Expression von rekombinantem, reifem lysostaphin - Google Patents

Expression von rekombinantem, reifem lysostaphin

Info

Publication number
ATE430799T1
ATE430799T1 AT99974124T AT99974124T ATE430799T1 AT E430799 T1 ATE430799 T1 AT E430799T1 AT 99974124 T AT99974124 T AT 99974124T AT 99974124 T AT99974124 T AT 99974124T AT E430799 T1 ATE430799 T1 AT E430799T1
Authority
AT
Austria
Prior art keywords
lysostaphin
mature lysostaphin
preprolysostaphin
prolysostaphin
mature
Prior art date
Application number
AT99974124T
Other languages
English (en)
Inventor
Ghan Shyam Khatri
Rahul Sharma
Original Assignee
Bharat Biotech International L
Council Of Scient & Ind Res C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Biotech International L, Council Of Scient & Ind Res C filed Critical Bharat Biotech International L
Application granted granted Critical
Publication of ATE430799T1 publication Critical patent/ATE430799T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT99974124T 1999-10-19 1999-10-19 Expression von rekombinantem, reifem lysostaphin ATE430799T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001704 WO2001029201A1 (en) 1999-10-19 1999-10-19 Expression of recombinant mature lysostaphin

Publications (1)

Publication Number Publication Date
ATE430799T1 true ATE430799T1 (de) 2009-05-15

Family

ID=11004914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99974124T ATE430799T1 (de) 1999-10-19 1999-10-19 Expression von rekombinantem, reifem lysostaphin

Country Status (13)

Country Link
US (1) US6897041B1 (de)
EP (1) EP1224271B1 (de)
JP (1) JP2003512050A (de)
KR (1) KR100635426B1 (de)
CN (1) CN1267551C (de)
AT (1) ATE430799T1 (de)
AU (1) AU784354B2 (de)
BR (1) BR9917526B1 (de)
CA (1) CA2388003C (de)
DE (1) DE69940859D1 (de)
MX (1) MXPA02003885A (de)
NZ (1) NZ518963A (de)
WO (1) WO2001029201A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE516356T1 (de) * 2001-12-21 2011-07-15 Biosynexus Inc Gestutzes lysostaphin-molekül mit verbesserter staphylolytischer wirkung
CN100475965C (zh) 2005-07-22 2009-04-08 上海高科联合生物技术研发有限公司 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法
WO2008105826A2 (en) * 2006-09-05 2008-09-04 Biosynexus Incorporated Compositions compromising lysostaphin variants and methods of using the same
CA2692800A1 (en) * 2007-07-09 2009-01-15 Christopher John Stanley Detection of micro-organisms based on their nad-dependent dna ligase activity
US20110044968A1 (en) * 2008-03-10 2011-02-24 Pharmal N Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
US8821860B2 (en) * 2009-08-07 2014-09-02 Lawrence Livermore National Security, Llc Targeted antimicrobials and related compositions, methods and systems
CN105579053B (zh) 2013-08-06 2021-08-31 达特茅斯学院理事会 非糖基化溶葡球菌素变体蛋白
EP3086805B1 (de) 2013-12-28 2018-10-03 Longhorn Vaccines and Diagnostics, LLC Verwendung von glycyl-glycine endopeptidase zur behandlung von mycobacteria infektionen
KR102195998B1 (ko) * 2019-09-27 2020-12-29 코스맥스 주식회사 스타필로코커스 시뮬란스 st-9 균주 및 그의 피부 상태 개선 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079159A (en) * 1983-12-27 1992-01-07 Genetics Institute, Inc. Method for making tissue plasminogen activator
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
JPH0811074B2 (ja) 1987-10-30 1996-02-07 財団法人化学及血清療法研究所 プレアルブミンをコードする遺伝子を組込んだ組換えプラスミドおよびこれを用いたプレアルブミンの製法
US5122457A (en) * 1989-10-19 1992-06-16 Schering Corporation Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase
US5530100A (en) * 1990-05-07 1996-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Methods for purification of recombinantly produced proteins
JP2552942B2 (ja) 1990-06-01 1996-11-13 三井東圧化学株式会社 ヒトｂーＦＧＦ受容体遺伝子
US5824528A (en) * 1992-05-01 1998-10-20 Associated Universities, Inc. Cloning and expression of autogenes encoding RNA poly,erases of T7-like bacteriophages
PL307474A1 (en) * 1992-08-14 1995-05-29 Commw Scient Ind Res Org Insects' viruses and their application in plant protection
DE4425645A1 (de) * 1994-07-20 1996-02-22 Mueller Karl & Co Kg Deletiertes Lysostaphingen von Staphylococcus simulans
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees
IL118473A0 (en) * 1995-06-02 1996-09-12 Suntory Ltd Staphylococcus aureus V8 protease genes coding therefor and a method for the production thereof
GB9614700D0 (en) * 1996-07-12 1996-09-04 Medical Res Council Over-expression of proteins in E.Coli
CA2211293A1 (en) * 1997-07-23 1999-01-23 Immunova Ltee Recombinant lysostaphin analogs

Also Published As

Publication number Publication date
WO2001029201A1 (en) 2001-04-26
AU784354B2 (en) 2006-03-16
CN1267551C (zh) 2006-08-02
AU5995599A (en) 2001-04-30
BR9917526B1 (pt) 2013-09-24
MXPA02003885A (es) 2005-06-03
BR9917526A (pt) 2002-06-11
NZ518963A (en) 2002-11-26
CA2388003A1 (en) 2001-04-26
KR100635426B1 (ko) 2006-10-18
EP1224271A4 (de) 2002-11-27
EP1224271B1 (de) 2009-05-06
CN1406278A (zh) 2003-03-26
KR20020064886A (ko) 2002-08-10
CA2388003C (en) 2013-02-19
JP2003512050A (ja) 2003-04-02
DE69940859D1 (de) 2009-06-18
US6897041B1 (en) 2005-05-24
EP1224271A1 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
DE69940859D1 (de) Expression von rekombinantem, reifem lysostaphin
ATE254175T1 (de) Mit einem neuen plasmid transformierter e.coli stamm jm83/pkp2 und damit hergestellte phytase
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
KR970706806A (ko) 신규한 아데노바이러스성 벡터, 패키징 세포주, 재조합 아데노바이러스와 그 방법(novel adenoviral vectors, packagning cell lines, recombinant adenoviruses and methods)
WO2001087958A3 (en) CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS
DK0605501T5 (da) Anvendelse af præsynaptisk neurotoksin til behandling af cerebel parese
BR0317696A (pt) Composição para branqueamento
DK1312679T3 (da) Rekombinant MVA-virus og anvendelse deraf
ATE277947T1 (de) Antitumorale zusammenstellung von immunogene polypetiden mit veränderter zellokalisierung
PT1311504E (pt) Tetrazolil-fenil-acetamidas activadoras da glucoquinase
DE69333951D1 (de) Rekombinantes pseudomonas exotoxin mit gesteigerter aktivität
EP0933995B8 (de) Verfahren zur behandlung von endothelialen verletzungen
EP1651166A4 (de) Polypeptide zur induktion einer schützenden immunantwort gegen staphylococcus aureus
CY1112957T1 (el) Μη νευροτοξικοι παραγοντες, οι οποιοι ενεργοποιουν το πλασμινογονο για τη θεραπευτικη αγωγη εγκεφαλικου επεισοδιου
NO990086L (no) Avkortete, l°selige tumornekrosefaktorreseptorer av type I og type II
ATE516356T1 (de) Gestutzes lysostaphin-molekül mit verbesserter staphylolytischer wirkung
WO2002024930A3 (en) Artificial ubiquitous chromatin opening elements (ucoe)
DE60121346T8 (de) Suppressor-Gen
BR9607583B1 (pt) plasmìdios procarióticos recombinantes.
ATE199168T1 (de) Stabilisierung von plasmiden
DE69133485D1 (de) Verwendung von Staphylococcus Enterotoxin Homologe für Krebs-Therapie
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
DE69933990D1 (de) Hocheffiziente und kontrollierte expression von exogenen genen in e. coli
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
ATE377648T1 (de) Escherichia coli hochexpressionsvektor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties